Ke Zhang, Qing He, Qin Cao, Jun Chuan, Ang Qin, Lin Tang, Xinyue Zhang, Changhe Xiao, Biyin Zhu, Meiling Hu, Lei Chang, Zhong Xin Bu, Lanqi Fu, Ting Yang, Yu Wang, Weidong Liu
{"title":"评估 SDC2/NDRG4 甲基化在结直肠癌检测中的临床表现。","authors":"Ke Zhang, Qing He, Qin Cao, Jun Chuan, Ang Qin, Lin Tang, Xinyue Zhang, Changhe Xiao, Biyin Zhu, Meiling Hu, Lei Chang, Zhong Xin Bu, Lanqi Fu, Ting Yang, Yu Wang, Weidong Liu","doi":"10.2217/epi-2023-0290","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> The performance and clinical accuracy of combined <i>SDC2/NDRG4</i> methylation were evaluated in diagnosing colorectal cancer (CRC) and advanced adenoma. <b>Methods:</b> A total of 2333 participants were enrolled to assess the sensitivity and specificity of biomarkers in diagnosing CRC in a multicenter clinical trial through feces DNA methylation tests. <b>Results:</b> <i>SDC2/NDRG4</i> methylation showed excellent performance for CRC detection in biomarker research and the real world. Its sensitivity for detecting CRC, early CRC and advanced adenoma were 92.06%, 91.45% and 62.61%, respectively. Its specificity was 94.29%, with a total coincidence rate of 88.28%. When interference samples were included, the specificity was still good (82.61%). Therefore, the <i>SDC2/NDRG4</i> methylation test showed excellent performance in detecting CRC and advanced adenoma under clinical application.</p>","PeriodicalId":11959,"journal":{"name":"Epigenomics","volume":" ","pages":"93-108"},"PeriodicalIF":3.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluating the clinical performance of <i>SDC2/NDRG4</i> methylation for colorectal cancer detection.\",\"authors\":\"Ke Zhang, Qing He, Qin Cao, Jun Chuan, Ang Qin, Lin Tang, Xinyue Zhang, Changhe Xiao, Biyin Zhu, Meiling Hu, Lei Chang, Zhong Xin Bu, Lanqi Fu, Ting Yang, Yu Wang, Weidong Liu\",\"doi\":\"10.2217/epi-2023-0290\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Purpose:</b> The performance and clinical accuracy of combined <i>SDC2/NDRG4</i> methylation were evaluated in diagnosing colorectal cancer (CRC) and advanced adenoma. <b>Methods:</b> A total of 2333 participants were enrolled to assess the sensitivity and specificity of biomarkers in diagnosing CRC in a multicenter clinical trial through feces DNA methylation tests. <b>Results:</b> <i>SDC2/NDRG4</i> methylation showed excellent performance for CRC detection in biomarker research and the real world. Its sensitivity for detecting CRC, early CRC and advanced adenoma were 92.06%, 91.45% and 62.61%, respectively. Its specificity was 94.29%, with a total coincidence rate of 88.28%. When interference samples were included, the specificity was still good (82.61%). Therefore, the <i>SDC2/NDRG4</i> methylation test showed excellent performance in detecting CRC and advanced adenoma under clinical application.</p>\",\"PeriodicalId\":11959,\"journal\":{\"name\":\"Epigenomics\",\"volume\":\" \",\"pages\":\"93-108\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Epigenomics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2217/epi-2023-0290\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/16 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epigenomics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2217/epi-2023-0290","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/16 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
Evaluating the clinical performance of SDC2/NDRG4 methylation for colorectal cancer detection.
Purpose: The performance and clinical accuracy of combined SDC2/NDRG4 methylation were evaluated in diagnosing colorectal cancer (CRC) and advanced adenoma. Methods: A total of 2333 participants were enrolled to assess the sensitivity and specificity of biomarkers in diagnosing CRC in a multicenter clinical trial through feces DNA methylation tests. Results:SDC2/NDRG4 methylation showed excellent performance for CRC detection in biomarker research and the real world. Its sensitivity for detecting CRC, early CRC and advanced adenoma were 92.06%, 91.45% and 62.61%, respectively. Its specificity was 94.29%, with a total coincidence rate of 88.28%. When interference samples were included, the specificity was still good (82.61%). Therefore, the SDC2/NDRG4 methylation test showed excellent performance in detecting CRC and advanced adenoma under clinical application.
期刊介绍：
Epigenomics provides the forum to address the rapidly progressing research developments in this ever-expanding field; to report on the major challenges ahead and critical advances that are propelling the science forward. The journal delivers this information in concise, at-a-glance article formats – invaluable to a time constrained community.
Substantial developments in our current knowledge and understanding of genomics and epigenetics are constantly being made, yet this field is still in its infancy. Epigenomics provides a critical overview of the latest and most significant advances as they unfold and explores their potential application in the clinical setting.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
